HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX)
CUSIP: 427746102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 182,615,507
- Total 13F shares
- 129,609,461
- Share change
- +10,065,549
- Total reported value
- $453,638,008
- Put/Call ratio
- 156%
- Price per share
- $3.50
- Number of holders
- 189
- Value change
- +$35,415,047
- Number of buys
- 109
- Number of sells
- 52
Quarterly Holders Quick Answers
What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 427746102:
Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rubric Capital Management LP |
13F
|
Company |
15%
|
26,713,503
|
$73,996,403 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
5.5%
|
10,111,550
|
$28,008,994 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.4%
|
8,114,716
|
$22,477,763 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4%
|
7,286,028
|
$20,182,297 | — | 31 Mar 2024 | |
| Velan Capital Investment Management LP |
13F
3/4/5
|
Company · Other* |
3.8%
|
6,986,744
|
$19,353,281 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.5%
|
6,374,584
|
$17,657,598 | — | 31 Mar 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
2.4%
|
4,411,567
|
$12,220,041 | — | 31 Mar 2024 | |
| PALISADE CAPITAL MANAGEMENT, LP |
13F
|
Company |
2%
|
3,732,241
|
$10,338,308 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.7%
|
3,167,286
|
$8,773,382 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.6%
|
2,910,011
|
$8,060,730 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
2,796,119
|
$7,746,588 | — | 31 Mar 2024 | |
| Clearline Capital LP |
13F
|
Company |
1.5%
|
2,776,204
|
$7,690,085 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.5%
|
2,695,046
|
$7,465,277 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
2,440,870
|
$6,761,210 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
2,406,486
|
$6,666,000 | — | 31 Mar 2024 | |
| JW Asset Management, LLC |
13F
|
Company |
1.3%
|
2,292,418
|
$6,349,998 | — | 31 Mar 2024 | |
| Orchard Capital Management, LLC |
13F
|
Company |
1.2%
|
2,271,883
|
$6,293,116 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
1,850,000
|
$5,124,500 | — | 31 Mar 2024 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.99%
|
1,813,164
|
$5,022,464 | — | 31 Mar 2024 | |
| Congress Park Capital LLC |
13F
|
Company |
0.9%
|
1,644,785
|
$4,556,055 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.77%
|
1,400,404
|
$3,879,119 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.6%
|
1,094,687
|
$3,032,283 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.6%
|
1,094,116
|
$3,030,701 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
1,091,138
|
$3,022,452 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
959,550
|
$2,657,954 | — | 31 Mar 2024 | |
| Barry D. Quart |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,142,796
mixed-class rows
|
$2,142,511 | — | 18 Jan 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.31%
|
573,437
|
$1,588,420 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.31%
|
561,984
|
$1,556,696 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.27%
|
494,354
|
$1,369,360 | — | 31 Mar 2024 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
493,264
|
$1,366,341 | — | 31 Mar 2024 | |
| NEXPOINT ASSET MANAGEMENT, L.P. |
13F
|
Company |
0.26%
|
475,750
|
$1,317,828 | — | 31 Mar 2024 | |
| Kevin Kotler |
3/4/5
|
Director |
—
class O/S missing
|
577,879
|
$1,242,440 | — | 22 Feb 2023 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.24%
|
436,473
|
$1,209,031 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.23%
|
417,985
|
$1,157,819 | — | 31 Mar 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.21%
|
375,426
|
$1,039,930 | — | 31 Mar 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.19%
|
338,526
|
$938,000 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
335,557
|
$929,493 | — | 31 Mar 2024 | |
| Zweig-DiMenna Associates LLC |
13F
|
Company |
0.18%
|
320,130
|
$886,760 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.18%
|
319,943
|
$886,240 | — | 31 Mar 2024 | |
| CM Management, LLC |
13F
|
Company |
0.16%
|
300,000
|
$831,000 | — | 31 Mar 2024 | |
| Richmond Brothers, Inc. |
13F
|
Company |
0.16%
|
296,706
|
$821,876 | — | 31 Mar 2024 | |
| KBC Group NV |
13F
|
Company |
0.16%
|
289,269
|
$801,000 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.15%
|
279,699
|
$775,000 | — | 31 Mar 2024 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.15%
|
274,510
|
$760,393 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.15%
|
268,463
|
$743,642 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.13%
|
235,042
|
$651,066 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.11%
|
208,787
|
$578,340 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
198,999
|
$551,229 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
185,898
|
$514,937 | — | 31 Mar 2024 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0.09%
|
171,000
|
$473,670 | — | 31 Mar 2024 |
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q2 2024
As of 30 Jun 2024,
HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
129,609,461 shares.
The largest 10 holders included
Rubric Capital Management LP, VANGUARD GROUP INC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Velan Capital Investment Management LP, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, STATE STREET CORP, Tejara Capital Ltd, and PALISADE CAPITAL MANAGEMENT, LP.
This page lists
190
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
157
Q2 2024 holders
189
Holder diff
32
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.